Search

Your search keyword '"Separovic, F."' showing total 423 results

Search Constraints

Start Over You searched for: Author "Separovic, F." Remove constraint Author: "Separovic, F."
423 results on '"Separovic, F."'

Search Results

251. Solid-state NMR of amyloid membrane interactions.

252. Design and development of analogues of dimers of insulin-like peptide 3 B-chain as high-affinity antagonists of the RXFP2 receptor.

253. Anionic phospholipid interactions of the prion protein N terminus are minimally perturbing and not driven solely by the octapeptide repeat domain.

254. Real-time quantitative analysis of lipid disordering by aurein 1.2 during membrane adsorption, destabilisation and lysis.

255. NMR relaxation and self-diffusion study at high and low magnetic fields of ionic association in protic ionic liquids.

256. Self-assembly of peptides into spherical nanoparticles for delivery of hydrophilic moieties to the cytosol.

257. Solid-state NMR and simulation studies of equinatoxin II N-terminus interaction with lipid bilayers.

258. Preparation of protic ionic liquids with minimal water content and (15)N NMR study of proton transfer.

259. Solid-state NMR study of membrane interactions of the pore-forming cytolysin, equinatoxin II.

260. Effect of helix-promoting strategies on the biological activity of novel analogues of the B-chain of INSL3.

261. Solution structure and membrane interactions of the antimicrobial peptide fallaxidin 4.1a: an NMR and QCM study.

262. Cubic phases of ternary amphiphile-water systems.

263. Effect of lipid on the conformation of the N-terminal region of equinatoxin II: a synchrotron radiation circular dichroism spectroscopic study.

264. Membrane interactions of antimicrobial peptides from Australian frogs.

265. Development of lanthanide-labeled human INSL3 as an alternative probe to radioactively labeled INSL3 for use in bioassays.

266. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.

267. The human insulin superfamily of polypeptide hormones.

268. The effects of lipids on the structure of the eukaryotic cytolysin equinatoxin II: a synchrotron radiation circular dichroism spectroscopic study.

269. Effect of antimicrobial peptides from Australian tree frogs on anionic phospholipid membranes.

270. Solid-phase synthesis of europium-labeled human INSL3 as a novel probe for the study of ligand-receptor interactions.

271. A solid-state NMR study of the interaction of fish antifreeze proteins with phospholipid membranes.

272. Liposomal phospholipid preparations of chloramphenicol for ophthalmic applications.

273. Electrochemistry of room temperature protic ionic liquids.

274. Metal effects on the membrane interactions of amyloid-beta peptides.

276. Cholesterol and Clioquinol modulation of A beta(1-42) interaction with phospholipid bilayers and metals.

277. Specific and selective peptide-membrane interactions revealed using quartz crystal microbalance.

278. Characterisation of the extracellular polysaccharides produced by isolates of the fungus Acremonium.

279. Interactions of the Australian tree frog antimicrobial peptides aurein 1.2, citropin 1.1 and maculatin 1.1 with lipid model membranes: differential scanning calorimetric and Fourier transform infrared spectroscopic studies.

280. Membrane interactions and the effect of metal ions of the amyloidogenic fragment Abeta(25-35) in comparison to Abeta(1-42).

281. Boltzmann statistics rotational-echo double-resonance analysis.

282. beta-Sheet structured beta-amyloid(1-40) perturbs phosphatidylcholine model membranes.

283. The conformation of acetylated virginiamycin M1 and virginiamycin M1 in explicit solvents.

284. Cupiennin 1a, an antimicrobial peptide from the venom of the neotropical wandering spider Cupiennius salei, also inhibits the formation of nitric oxide by neuronal nitric oxide synthase.

285. Selective permeabilization of the host cell membrane of Plasmodium falciparum-infected red blood cells with streptolysin O and equinatoxin II.

286. Solution structure and interaction of cupiennin 1a, a spider venom peptide, with phospholipid bilayers.

287. Membrane interactions of antimicrobial peptides from Australian tree frogs.

288. Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge.

289. Interfacial properties of the M1 segment of the nicotinic acetylcholine receptor.

290. Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions.

291. Structure and activity of the N-terminal region of the eukaryotic cytolysin equinatoxin II.

292. Dimerisation of N-acetyl-L-tyrosine ethyl ester and Abeta peptides via formation of dityrosine.

293. Direct visualization of membrane leakage induced by the antibiotic peptides: maculatin, citropin, and aurein.

294. Postsynthesis vapor-phase functionalization of MCM-48 with hexamethyldisilazane and 3-aminopropyldimethylethoxylsilane for bioseparation applications.

295. The role of Abeta peptides in Alzheimer's disease.

296. The conformational flexibility of the antibiotic virginiamycin M(1).

297. Methionine regulates copper/hydrogen peroxide oxidation products of Abeta.

298. Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide.

299. 29Si NMR study of structural ordering in aluminosilicate geopolymer gels.

300. Interaction of the eukaryotic pore-forming cytolysin equinatoxin II with model membranes: 19F NMR studies.

Catalog

Books, media, physical & digital resources